Studies on glycosphingolipid biosynthesis by lectin-stimulated human lymphocytes. 1980

C Vakirtzi-Lemonias, and G P Evangelatos, and V M Kapoulas, and G M Levis

1. Human peripheral lymphocytes, normal and stimulated by phytohemagglutinin or concanavalin A. were investigated with respect to their ability to biosynthesize neutral and acidic glycosphingolipids from D-[U-14C]glucose, D-[U-14C]galactose and D-[U-14C]glucosamine as precursors. 2. Galactose and glucosamie are taken up selectively, in the presence of excessive glucose concentrations. Labeling of total neutral glycosphingolipids from D-[U-14]galactose in normal cells decreases after the first 6 h while in stimulated cells there is a fourfold and a sevenfold increase after 6 and 12 h of incubation respectively. Under similar conditions stimulation with concanavalin A gives a fourfold increase after 12 h of incubation. 3. Analysis of individual glycosphingolipids biosynthesized from [U-14C]galactose shows that lactosylceramide is the major radioactive neutral glycosphingolipid and that stimulation by phytohemagglutinin yields an almost sevenfold and 13-fold increase in the radioactivity incorporated within 6 and 12 h of incubation respectively. Glucosylceramide shows about an eightfold increase, globotetraosylceramide a threefold increase and globotriaosylceramide a fourfold increase. The rate of incorporation into glucosylceramide of stimulated lymphocytes declines after 6 h of incubation, accompanied by a concomitant increase of incorporation into lactosylceramide. 4. At 12 h of incubation the ratios of radioactivities incorporated into neutral glycosphingolipids of phytohemagglutinin-stimulated cells compared to normal cells were 1.0 for D-[U-14C]glucose 7.0 for D-[U-14C]galactose and 2.5 for D-[U-14C]glucosamine. Respective ratios for lactosylceramide are 1.0 for [U-14C]glucose and 13.0 for [U-14C]galactose. These differences did not arise from changes of the uptake of the glycosyl precursor by the cell due to stimulation. 5. Incorporation of D-[U-14C]galactose into II3-N-acetylneuraminosyllactosylceramide by cells stimulated by phytohemagglutinin and concanavalin A is enhanced 14-times and 15-times respectively. With [U-14C]glucosamine as precursor, this increase in the labeling is much more impressive, 80-fold after 12 h of incubation by the phytohemagglutinin-stimulated lymphocytes. Neuraminidase treatment and gas radiochromatographic analysis of the labeled compound derived from [U-14C]-galactose as precursor indicate that 89% of the radioactivity was incorporated into the glucosyl and galactosyl moieties, in a ratio 1:1. With [U-14C]glucosamine as precursor, a selective labeling of the sialyl moiety of the II3-N-acetylneuraminosyllactosylceramide was indicated. 6. The pattern of complex gangliosides (more complex than II3-N-acetylneuraminosyllactosylceramide) which are biosynthesized after phytohemagglutinin stimulation of the cells, show no significant differences when compared to the patterns obtained from normal cells.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D008214 Lymphocytes White blood cells formed in the body's lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic (if any) granules. Most lymphocytes can be classified as either T or B (with subpopulations of each), or NATURAL KILLER CELLS. Lymphoid Cells,Cell, Lymphoid,Cells, Lymphoid,Lymphocyte,Lymphoid Cell
D009439 Neuraminidase An enzyme that catalyzes the hydrolysis of alpha-2,3, alpha-2,6-, and alpha-2,8-glycosidic linkages (at a decreasing rate, respectively) of terminal sialic residues in oligosaccharides, glycoproteins, glycolipids, colominic acid, and synthetic substrate. (From Enzyme Nomenclature, 1992) Sialidase,Exo-alpha-Sialidase,N-Acylneuraminate Glycohydrolases,Oligosaccharide Sialidase,Exo alpha Sialidase,Glycohydrolases, N-Acylneuraminate,N Acylneuraminate Glycohydrolases,Sialidase, Oligosaccharide
D005690 Galactose An aldohexose that occurs naturally in the D-form in lactose, cerebrosides, gangliosides, and mucoproteins. Deficiency of galactosyl-1-phosphate uridyltransferase (GALACTOSE-1-PHOSPHATE URIDYL-TRANSFERASE DEFICIENCY DISEASE) causes an error in galactose metabolism called GALACTOSEMIA, resulting in elevations of galactose in the blood. D-Galactose,Galactopyranose,Galactopyranoside,D Galactose
D005944 Glucosamine 2-Amino-2-Deoxyglucose,Dona,Dona S,Glucosamine Sulfate,Hespercorbin,Xicil,2 Amino 2 Deoxyglucose,Sulfate, Glucosamine
D005947 Glucose A primary source of energy for living organisms. It is naturally occurring and is found in fruits and other parts of plants in its free state. It is used therapeutically in fluid and nutrient replacement. Dextrose,Anhydrous Dextrose,D-Glucose,Glucose Monohydrate,Glucose, (DL)-Isomer,Glucose, (alpha-D)-Isomer,Glucose, (beta-D)-Isomer,D Glucose,Dextrose, Anhydrous,Monohydrate, Glucose
D006028 Glycosphingolipids Lipids containing at least one monosaccharide residue and either a sphingoid or a ceramide (CERAMIDES). They are subdivided into NEUTRAL GLYCOSPHINGOLIPIDS comprising monoglycosyl- and oligoglycosylsphingoids and monoglycosyl- and oligoglycosylceramides; and ACIDIC GLYCOSPHINGOLIPIDS which comprises sialosylglycosylsphingolipids (GANGLIOSIDES); SULFOGLYCOSPHINGOLIPIDS (formerly known as sulfatides), glycuronoglycosphingolipids, and phospho- and phosphonoglycosphingolipids. (From IUPAC's webpage) Asialoganglioside,Asialogangliosides,Glycosphingolipid,Sphingoglycolipid,Sphingoglycolipids
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D037102 Lectins Proteins that share the common characteristic of binding to carbohydrates. Some ANTIBODIES and carbohydrate-metabolizing proteins (ENZYMES) also bind to carbohydrates, however they are not considered lectins. PLANT LECTINS are carbohydrate-binding proteins that have been primarily identified by their hemagglutinating activity (HEMAGGLUTININS). However, a variety of lectins occur in animal species where they serve diverse array of functions through specific carbohydrate recognition. Animal Lectin,Animal Lectins,Isolectins,Lectin,Isolectin,Lectin, Animal,Lectins, Animal

Related Publications

C Vakirtzi-Lemonias, and G P Evangelatos, and V M Kapoulas, and G M Levis
December 1976, Biochemical and biophysical research communications,
C Vakirtzi-Lemonias, and G P Evangelatos, and V M Kapoulas, and G M Levis
July 1995, European journal of immunology,
C Vakirtzi-Lemonias, and G P Evangelatos, and V M Kapoulas, and G M Levis
January 1973, Acta chemica Scandinavica,
C Vakirtzi-Lemonias, and G P Evangelatos, and V M Kapoulas, and G M Levis
June 1999, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie,
C Vakirtzi-Lemonias, and G P Evangelatos, and V M Kapoulas, and G M Levis
August 2019, Analytical chemistry,
C Vakirtzi-Lemonias, and G P Evangelatos, and V M Kapoulas, and G M Levis
April 1970, The Tohoku journal of experimental medicine,
C Vakirtzi-Lemonias, and G P Evangelatos, and V M Kapoulas, and G M Levis
January 1982, Canadian journal of genetics and cytology. Journal canadien de genetique et de cytologie,
C Vakirtzi-Lemonias, and G P Evangelatos, and V M Kapoulas, and G M Levis
June 1986, Proceedings of the National Academy of Sciences of the United States of America,
C Vakirtzi-Lemonias, and G P Evangelatos, and V M Kapoulas, and G M Levis
May 1968, The Journal of cell biology,
C Vakirtzi-Lemonias, and G P Evangelatos, and V M Kapoulas, and G M Levis
February 1973, Annals of clinical research,
Copied contents to your clipboard!